Reading Time: 2 minutesIntroduction Non-Alcoholic Fatty Liver Disease (NAFLD) represents a significant health concern among American males, often linked to obesity and metabolic syndrome. Recent studies have begun to explore the potential benefits of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in managing …